NCT05080920View on ClinicalTrials.gov

Rosmalip® for Cancer Infections Prevention

NACompletedINTERVENTIONAL
Enrollment

109

Participants

Timeline

Start Date

October 28, 2020

Primary Completion Date

September 30, 2022

Study Completion Date

December 31, 2022

Conditions
InfectionsCovid19Cancer
Interventions
DIETARY_SUPPLEMENT

Rosmalip®

Nutritional Supplement+Usual Care

OTHER

Placebo

Placebo+Usual Care

Trial Locations (1)

28134

Servicio de Oncología. Hospital Infanta Sofía., San Sebastián de los Reyes

All Listed Sponsors
collaborator

IMDEA Food

OTHER

collaborator

Universidad Autonoma de Madrid

OTHER

lead

Fundación Investigación E Innovación Biomédica Hospital Universitario Infanta Sofia-Henares

OTHER

NCT05080920 - Rosmalip® for Cancer Infections Prevention | Biotech Hunter | Biotech Hunter